Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia

Singapore Medical Journal

Volumn 51, Issue 2, 2010, Pages 110-115

  Ahmad, R ^a   Tripathi, A K ^a   Tripathi, P ^a   Singh, R ^a   Singh, S ^a   Singh, R K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Chronic myeloid leukaemia; Oxidative stress; Response marker

Indexed keywords

CYTODROX; GLUTATHIONE; HYDROXYUREA; IMATINIB; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; SPECTROPHOTOMETRY; TREATMENT RESPONSE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GLUTATHIONE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SULFHYDRYL COMPOUNDS;

EID: 77951290573     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Galli F, Piroddi M, Annetti C, et al. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005; 149:240-60.
2. Singh R, Singh RK, Mahdi AA, et al. Circadian periodicity of plasma lipid peroxides and other anti-oxidants as putative markers in gynecological malignancies. In Vivo 2003; 17:593-600.
3. Singh R, Singh RK, Tripathi AK, et al. Chronomics of circulating plasma lipid peroxides and anti-oxidant enzymes and other related molecules in cirrhosis of liver. In the memory of late Shri Chetan Singh. Biomed Pharmacother 2005; 59 suppl 1:S229-35.
4. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52:601-23.
5. Irshad M, Chaudhuri PS. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol 2002; 40:1233-9.
6. Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K. Lipid peroxidation and antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res 2005; 122:529-34.
7. Di Giacomo C, Acquaviva R, Lanteri R, et al. Nonproteic antioxidant status in plasma of subjects with colon cancer. Exp Biol Med (Maywood) 2003; 228:525-8.
8. Ghalaut VS, Ghalaut PS, Singh S. Lipid peroxidation in leukaemia. J Assoc Physicians India 1999; 47:403-5.
9. Tandon R, Behl D, Khanna R, Khanna HD. A study of oxidative stress in leukemia. J Int Med Ind 2002; 5:173-5.
10. Ghalaut PS, Kharb S, Singh GP. Plasma concentrations of lipid peroxidation products in children with acute leukaemia. Ind J Med Res 2001; 55:215-7.
11. Hammouda AE, Soliman SF, Tolba KA, el-Kabbany ZA, Makhlouf MS. Plasma concentrations of lipid peroxidation products in children with acute lymphoblastic leukemia. Clin Chem 1992; 38:594-5.
12. Czeczot H, Scibior D, Skrzycki M, Podsiad M. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol 2006; 53:237-42.
13. Navarro J, Obrador E, Carretero J, et al. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med 1999; 26:410-8.
14. Uzun H, Konukoglu D, Gelisgen R, Zengin K, Taskin M. Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obesity Surgery 2007; 17:1367-73.
15. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186:421-31.
16. Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 1994; 233:182-9.
17. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61:882-8.
18. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380-5.
19. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:47-95.
20. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A:30-8.
21. Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227:375-81.
22. Cerutti PA. Oxy-radicals and cancer. Lancet 1994; 344:862-3.
23. Geetha A, Karthiga S, Surendran G, Jayalakshmi G. Biochemical studies on the level of lipid hydroperoxide and antioxidants in different types of obstructive jaundice. J Lab Med 2001; 2:20-7.
24. Oberley LW, Oberley TD. Role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem 1988; 84:147-53.
25. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990; 8:583-99.
26. Bakan N, Taysi S, Yilmaz O, et al. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismautase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic myeloid leukemia. Clin Chem Acta 2003; 338:143-9.
27. Kharb S, Singh V, Ghalaut PS, Sharma A, Singh GP. Glutathione levels in health and sickness. Indian J Med Sci 2000; 54:52-4.
28. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; s134:489-92.
29. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press, 1999.
30. Andersson A, Lindgren A, Arnadottir M, Prytz H, Hultberg B. Thiols as a measure of plasma redox status in healthy subjects and in patients with renal or liver failure. Clin Chem 1999; 45:1084-7.
31. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 1997; 23:209-40.
32. Sangeetha P, Das UN, Koratkar R, Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990; 8:15-9.
33. Lauterburg BH, Nguyen T, Hartmann B, et al. Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/ mesna therapy. Cancer Chemother Pharmacol 1994; 35:132-6.
34. Sattler M, Verma S, Shrikhande G, et al. The BCR/ABL tryrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000; 275:24273-8.
35. Druker BJ, Guilhot F, O'Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355:2408-17.